Bachelor of Science in Biomedical Sciences (UB), Master of Science in Business Management applied to the Biotechnology Sector and Pharmaceutical Industry, specialized in Project Management (BBI) and Postgraduate course in Financing (UPF Barcelona School of Management). Principal at Invivo Partners, having joined the firm in 2020. She is Observer of the Board of Directors at Peptomyc, Integra, Telomere Therapeutics and EsoBiotec. Previously a Project Manager at UPF Ventures, an innovation management firm owned by Universitat Pompeu Fabra. She usually collaborates with different agents of the health innovation ecosystem as an evaluator of innovation projects and start-ups (COMB, EIT Health, CIMTI, The Collider, among others).